These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 27510823

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
    Roy A, Roberts I, Vyas P.
    Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
    [Abstract] [Full Text] [Related]

  • 3. [Myeloid proliferations related to Down syndrome].
    Hasegawa D.
    Rinsho Ketsueki; 2019 Aug; 60(9):1299-1307. PubMed ID: 31597856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical, cytogenetic, and molecular analyses of 17 neonates with transient abnormal myelopoiesis and nonconstitutional trisomy 21.
    Yuzawa K, Terui K, Toki T, Kanezaki R, Kobayashi A, Sato T, Kamio T, Kudo K, Sasaki S, Endo M, Ozono S, Nomura K, Ito E.
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28188. PubMed ID: 32020774
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hematological disorders in children with Down syndrome.
    Triarico S, Trombatore G, Capozza MA, Romano A, Mastrangelo S, Attinà G, Maurizi P, Ruggiero A.
    Expert Rev Hematol; 2022 Feb; 15(2):127-135. PubMed ID: 35184659
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Leukemogenesis in infants and young children with trisomy 21.
    Roberts I.
    Hematology Am Soc Hematol Educ Program; 2022 Dec 09; 2022(1):1-8. PubMed ID: 36485097
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome.
    Garnett C, Cruz Hernandez D, Vyas P.
    IUBMB Life; 2020 Jan 09; 72(1):119-130. PubMed ID: 31769932
    [Abstract] [Full Text] [Related]

  • 18. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations.
    Nakashima MO, Shetty S, Chicka M, Flagg A, Eng C, Cotta CV.
    Pediatr Blood Cancer; 2015 Feb 09; 62(2):353-355. PubMed ID: 25175265
    [Abstract] [Full Text] [Related]

  • 19. Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.
    van den Akker TA, Liu YC, Liu H, Chapman J, Levine JM, Weinberg OK, Geyer JT.
    Pathobiology; 2024 Feb 09; 91(1):89-98. PubMed ID: 36996802
    [Abstract] [Full Text] [Related]

  • 20. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
    Toki T, Kanezaki R, Kobayashi E, Kaneko H, Suzuki M, Wang R, Terui K, Kanegane H, Maeda M, Endo M, Mizuochi T, Adachi S, Hayashi Y, Yamamoto M, Shimizu R, Ito E.
    Blood; 2013 Apr 18; 121(16):3181-4. PubMed ID: 23440243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.